Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 3.4B | 3.5B | 4.3B | 2.4B |
Cost of revenue | 126.6M | 129.8M | 131.5M | 115.6M |
Gross profit | 3.2B | 3.4B | 4.2B | 2.2B |
Operating expense | ||||
Research & development | 250.3M | 248.5M | 294.1M | 292.6M |
Selling general and admin | -174.2M | 663.8M | -956.6M | 1.5B |
Other operating expenses | 84.2M | 29.7M | 168.0M | -42.1M |
Operating income | 2.6B | 2.4B | 3.1B | 1.5B |
Non operating interest income | ||||
Income | 38.5M | 41.2M | 57.5M | 51.3M |
Expense | 17.5M | 12.1M | 29.9M | 17.4M |
Other income expense | — | — | — | — |
Pretax income | 3.3B | 3.1B | 4.0B | 2.3B |
Tax provision | 457.6M | 423.5M | 478.1M | 296.1M |
Net income | 2.9B | 2.7B | 3.6B | 2.0B |
Basic EPS | — | 0.2 | — | — |
Diluted EPS | — | 0.2 | — | — |
Basic average shares | — | 15.8B | — | — |
Diluted average shares | — | 15.8B | — | — |
EBITDA | 3.6B | 3.1B | 4.2B | 2.4B |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |